Effects of trans-endocardial delivery of bone marrow-derived CD133+ cells on angina and quality of life in patients with refractory angina: A sub-analysis of the REGENT-VSEL trial.
Jadczyk T, Ciosek J, Michalewska-Wludarczyk A, Szot W, Parma Z, Ochala B, Markiewicz M, Rychlik W, Kostkiewicz M, Gruszczynska K, Blach A, Dzierzak-Mietla M, Rzeszutko L, Partyka L, Zasada W, Smolka G, Pawlowski T, Jedrzejek M, Starek Z, Plens K, Ochala A, Tendera M, Wojakowski W.
Jadczyk T, et al.
Cardiol J. 2018;25(4):521-529. doi: 10.5603/CJ.2018.0082.
Cardiol J. 2018.
PMID: 30211929
Free article.
Clinical Trial.